Comprehensive Identification of Tumor-associated Antigens via Isolation of Human Monoclonal Antibodies that may be Therapeutic
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Although the success of trastuzumab and rituximab for treatment of breast cancer and non-Hodgkins lymphoma, respectively, suggests that monoclonal antibodies (mAbs) will become important therapeutic agents against a wider range of cancers, useful therapeutic Abs are not yet available for the majority of the human cancers because of our lack of knowledge of which antigens (Ags) are likely to become useful targets. We established a procedure for comprehensive identification of such Ags through the extensive isolation of human mAbs that may be therapeutic. Using the phage-display Ab library we isolated a large number of human mAbs that bind to the surface of tumor cells. They were individually screened by immunostaining, and clones that preferentially and strongly stained the malignant cells were chosen. The Ags recognized by those clones were isolated by immunoprecipitation and identified by mass spectrometry (MS). We isolated 2,114 mAbs with unique sequences and identified 25 distinct Ags highly expressed on several carcinomas. Of those 2,114 mAbs 434 bound to specifically to one of the 25 Ags. I am going to discuss how we could select proper target Ags for therapeutic Abs and candidate clones as therapeutic agents.
Abstract
Although the success of trastuzumab and rituximab for treatment of breast cancer and non-Hodgkins lymphoma, respectively, suggests that monoclonal antibodies (mAbs) will become important therapeutic agents against a wider range of cancers, useful therapeutic Abs are not yet available for the majority of the human cancers because of our lack of knowledge of which antigens (Ags) are likely to become useful targets. We established a procedure for comprehensive identification of such Ags through the extensive isolation of human mAbs that may be therapeutic. Using the phage-display Ab library we isolated a large number of human mAbs that bind to the surface of tumor cells. They were individually screened by immunostaining, and clones that preferentially and strongly stained the malignant cells were chosen. The Ags recognized by those clones were isolated by immunoprecipitation and identified by mass spectrometry (MS). We isolated 2,114 mAbs with unique sequences and identified 25 distinct Ags highly expressed on several carcinomas. Of those 2,114 mAbs 434 bound to specifically to one of the 25 Ags. I am going to discuss how we could select proper target Ags for therapeutic Abs and candidate clones as therapeutic agents.
참고문헌 (10)
- Okabe H, "Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression", Cancer Res, 61, pp.2129~2137 (2001)
- Hippo Y, "Global gene expression analysis of gastric cancer by oligonucleotide microarrays", Cancer Res, 62, pp.233~240 (2002)
- Geuijen CAW, "A proteomic approach to tumor target identification using phage display, affinity purification and mass spectrometry", Eur J Cancer, 41, pp.178~187 (2005)
- Goenaga AL, "Identification and characterization of tumor antigens by using antibody phage display and intrabody strategies", Mol Immunol, 44, pp.3777~3788 (2007)
- Winter G, "Making antibodies by phage display technology", Annu RevImmunol, 12, pp.433~455 (1994)
- De Kruif J, "Rapid selection of cell subpopulation-specific human monoclonal antibodies from a synthetic phage antibody library", Proc Natl Acad Sci U S A, 92, pp.3938~3942 (1995)
- Kupsch JM, "Isolation of human tumor-specific antibodies by selection of an antibody phage library on melanoma cells", Clin Cancer Res, 5, pp.925~931 (1999)
- Akahori Y, "Isolation of antigen", antibody complexes through organic solvent (ICOS) method, 2009, pp.378, 832~835
- Kurosawa G, "Comprehensive screening for antigens overexpressed on carcinomas via isolation of human mAbs that may be therapeutic", Proc Natl Acad Sci U S A, 105, pp.7287~7292 (2008)
- Ito W, "Development of an artificial antibody system with multiple valency using an Fv fragment fused with a fragment of protein A", J Biol Chem, 268, pp.20668~20675 (1993)